The inhibition of allergen induced bronchospasm in man by oral BRL 10833
- PMID: 824069
- DOI: 10.1111/j.1365-2222.1976.tb01931.x
The inhibition of allergen induced bronchospasm in man by oral BRL 10833
Abstract
BRL 10833, a nitroindanedione, with DSCG like activity in rat immediate type hypersensitivity, shows good absorption after oral intake in man. The ingestion of 2 and 10 mg BRL 10833/kg body weight provides protection against the immediate type allergen induced bronchoconstriction in patients with bronchial asthma. These results confirm the activity of the drug shown by inhalation.